Biotechnological Method of Preparation and Characterization of Recombinant Antimicrobial Peptide Avicin A from Enterococcus avium


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Avicin A is a bacteriocin from the gram-positive bacterium Enterococcus avium. It exhibits a high microbicidal activity against bacteria of the genus Listeria, a causative agent of the severe human infection listeriosis. We developed a biotechnological method for obtaining avicin A and characterized its structure and biological activity. We also proposed a possible mechanism of the antimicrobial action of avicin A.

Sobre autores

S. Balandin

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Autor responsável pela correspondência
Email: arenicin@mail.ru
Rússia, Moscow, 117997

E. Finkina

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: arenicin@mail.ru
Rússia, Moscow, 117997

E. Nurmukhamedova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: arenicin@mail.ru
Rússia, Moscow, 117997

A. Tagaev

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: arenicin@mail.ru
Rússia, Moscow, 117997

E. Umnyakova

Institute of Experimental Medicine, Almazov National Medical Research Center

Email: arenicin@mail.ru
Rússia, St. Petersburg, 197341

V. Kokryakov

Institute of Experimental Medicine, Almazov National Medical Research Center

Email: arenicin@mail.ru
Rússia, St. Petersburg, 197341

V. Shvets

Lomonosov Institute of Fine Chemical Technology, Russian Technological University (MIREA)

Email: arenicin@mail.ru
Rússia, Moscow, 117571

T. Ovchinnikova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: arenicin@mail.ru
Rússia, Moscow, 117997

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Inc., 2019